Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2017: 3.556

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 36, Issue 5

Issues

Preparation of a Candidate Primary Reference Material for the International Standardisation of HbA1c Determinations

Andreas Finke / Uwe Kobold / Wieland Hoelzel / Cas Weykamp / Kor Miedema / Jan-Olof Jeppsson
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.1998.051

Abstract

We prepared a candidate primary reference material for the forthcoming international standardisation of β-N-terminal glycated hemoglobin A measurements. It consists of well-defined mixtures of purified β-N-terminal glycated hemoglobin A and non-glycated hemoglobin A.

First, β-N-terminal glycated hemoglobin A and non-glycated hemoglobin A were isolated, purified to homogeneity, and characterised. The techniques used were cation exchange and affinity chromatography for the purification, and high performance liquid chromatography, capillary isoelectric focusing, electrospray ionisation mass spectrometry, and peptide mapping for the characterisation. Hemoglobins from blood of healthy, non-diabetic volunteers were obtained with a purity of >99.5% for non-glycated hemoglobin A and of >98.5% for β-N-terminal glycated hemoglobin A. However, results from peptide mapping indicate that the β-N-terminal glycated hemoglobin A preparations still contain some non-β-N-terminal glycated hemoglobins, co-eluting with β-N-terminal glycated hemoglobin A. The exact content of β-N-terminal glycated hemoglobin A in these preparations could be determined by a procedure consisting of standard addition, enzymatic cleavage and quantification of the resulting β-Nterminal peptides to be in the range from 95–97.5%.

Since the β-N-terminal glycated hemoglobin A and non-glycated hemoglobin A content could be exactly determined in the materials prepared, mixtures of both components could be successfully used to calibrate the candidate reference methods.

About the article

Published Online: 2005-06-01

Published in Print: 1998-05-01


Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 36, Issue 5, Pages 299–308, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.1998.051.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Lin Ding, Yu Xu, Shanshan Liu, Yufang Bi, and Yiping Xu
Journal of Diabetes, 2018
[2]
Ilkka Penttilä, Karri Penttilä, Päivi Holm, Harri Laitinen, Päivi Ranta, Jukka Törrönen, and Rainer Rauramaa
World Journal of Methodology, 2016, Volume 6, Number 2, Page 133
[3]
K. Miedema
Diabetologia, 2004, Volume 47, Number 7, Page 1143
[4]
Kor Miedema
Scandinavian Journal of Clinical and Laboratory Investigation, 2005, Volume 65, Number sup240, Page 61
[5]
Randie R. Little and Curt L. Rohlfing
Laboratory Medicine, 2009, Volume 40, Number 6, Page 368
[6]
Tianjiao Zhang, Chuanbao Zhang, Wenxiang Chen, Haijian Zhao, Jiangtao Zhang, Weiyan Zhou, Jie Zeng, Jing Wang, and Donghuan Wang
Clinical Chemistry and Laboratory Medicine (CCLM), 2016, Volume 54, Number 4
[7]
Hong Liu, Lingkai Wong, Sharon Yong, Qinde Liu, and Tong Kooi Lee
Analytical and Bioanalytical Chemistry, 2015, Volume 407, Number 25, Page 7579
[8]
Xinyi Zhang, Katalin F Medzihradszky, John Cunningham, Phillip D.K Lee, Cheryl L Rognerud, Ching-Nan Ou, Paul Harmatz, and H.Ewa Witkowska
Journal of Chromatography B: Biomedical Sciences and Applications, 2001, Volume 759, Number 1, Page 1
[9]
Jung Min Kim and Dong-Jun Kim
Diabetes & Metabolism Journal, 2015, Volume 39, Number 1, Page 16
[10]
D. E. Goldstein, R. R. Little, R. A. Lorenz, J. I. Malone, D. Nathan, C. M. Peterson, and D. B. Sacks
Diabetes Care, 2004, Volume 27, Number 7, Page 1761
[11]
Shu Hwang Ang, M. Thevarajah, Yatimah Alias, and Sook Mei Khor
Clinica Chimica Acta, 2015, Volume 439, Page 202
[12]
P. Gillery
Médecine des Maladies Métaboliques, 2013, Volume 7, Number 3, Page 256
[13]
A. Helander and N. Kenan Moden
Alcohol and Alcoholism, 2013, Volume 48, Number 4, Page 478
[14]
Claudia Swart
Analytical and Bioanalytical Chemistry, 2013, Volume 405, Number 17, Page 5697
[15]
P. Gillery
EMC - Biologie médicale, 2009, Volume 4, Number 3, Page 1
[16]
Erna Lenters-Westra, Roger K. Schindhelm, Henk J. Bilo, and Robbert J. Slingerland
Diabetes Research and Clinical Practice, 2013, Volume 99, Number 2, Page 75
[17]
Sema Genc, Beyhan Omer, Esra Aycan-Ustyol, Nurhan Ince, Fatih Bal, and Figen Gurdol
Journal of Clinical Laboratory Analysis, 2012, Volume 26, Number 6, Page 481
[19]
C. Aulesa and N. Potau
Endocrinología y Nutrición, 2006, Volume 53, Number 3, Page 197
[20]
Estela del Castillo, Maria Montes-Bayón, Elena Añón, and Alfredo Sanz-Medel
Journal of Proteomics, 2011, Volume 74, Number 1, Page 35
[21]
D Chevenne and M Fonfrède
Immuno-analyse & Biologie Spécialisée, 2001, Volume 16, Number 4, Page 215
[22]
LM Thienpont
Immuno-analyse & Biologie Spécialisée, 2000, Volume 15, Number 6, Page 391
[23]
Hyung Geun Oh, Eun-Jung Rhee, Tae-Woong Kim, Kyung Bok Lee, Jeong-Ho Park, Kwang-Ik Yang, Dushin Jeong, and Hyung-Kook Park
Diabetes & Metabolism Journal, 2011, Volume 35, Number 5, Page 551
[24]
Annunziata Lapolla, Pietro Traldi, and Domenico Fedele
Clinical Biochemistry, 2005, Volume 38, Number 2, Page 103
[25]
Siv M. Osterman-Golkar and Hubert W. Vesper
Journal of Diabetes and its Complications, 2006, Volume 20, Number 5, Page 285
[26]
Linda M. Thienpont, Katleen Van Uytfanghe, and André P. De Leenheer
Clinica Chimica Acta, 2002, Volume 323, Number 1-2, Page 73
[27]
Toyofumi Nakanishi, Ayako Miyazaki, Akira Shimizu, Akifumi Yamaguchi, and Satoshi Nishimura
Clinica Chimica Acta, 2002, Volume 323, Number 1-2, Page 89
[28]
M. Panteghini and J.C. Forest
Clinica Chimica Acta, 2005, Volume 355, Number 1-2, Page 1
[29]
A. Lapolla, A. Mosca, and D. Fedele
Nutrition, Metabolism and Cardiovascular Diseases, 2011, Volume 21, Number 7, Page 467
[30]
Ken Iguchi, Toyofumi Nakanishi, Ayako Miyazaki, Akira Shimizu, and Akira Ota
Journal of Chromatography B, 2004, Volume 806, Number 1, Page 25
[31]
Akira Shimizu, Toyofumi Nakanishi, Masahiko Kishikawa, and Ayako Miyazaki
Journal of Chromatography B, 2002, Volume 776, Number 1, Page 15
[32]
YuCai Li, Jan-Olof Jeppsson, Magnus Jörntén-Karlsson, Eva Linné Larsson, Hans Jungvid, Igor Yu Galaev, and Bo Mattiasson
Journal of Chromatography B, 2002, Volume 776, Number 2, Page 149
[33]
Gabriella Bekő
Orvosi Hetilap, 2011, Volume 152, Number 14, Page 555
[34]
W. Garry John
Clinical Chemistry and Laboratory Medicine, 2003, Volume 41, Number 9
[35]
Yusheng Zhu, Laurie M. Williams, and Beverly D. Horne
Clinical Chemistry and Laboratory Medicine, 2010, Volume 48, Number 4
[36]
Mauro Panteghini and W. Garry John
Clinical Chemical Laboratory Medicine, 2007, Volume 45, Number 8
[37]
Randie R. Little
Clinical Chemistry and Laboratory Medicine, 2003, Volume 41, Number 9
[38]
GLAD Working Group (A delegates WG) Mosca, Maria Teresa Branca, Mariarosa Carta, Maria Ludovica Genna, Carlo B. Giorda, Rosangela Ghidelli, Germana Ghislandi, Dario Iafusco, Annunziata Lapolla, Vera Buondonno Lombardi, Carlo Augusto Lovagnini Scher, Maurizio Marra, Gerardo Medea, Franco Meschi, Andrea Pizzini, Francesco Rossi, Raffaele Scalpone, Gianni Tofini, Mariella Trovati, and Martina Zaninotto
Clinical Chemistry and Laboratory Medicine, 2010, Volume 48, Number 5
[39]
International Federation of Clinica Mosca, Ian Goodall, Tadao Hoshino, Jan O. Jeppsson, W. Garry John, Randie R. Little, Kor Miedema, Gary L. Myers, Hans Reinauer, David B. Sacks, and Cas W. Weykamp
Clinical Chemical Laboratory Medicine, 2007, Volume 45, Number 8
[40]
Jan-Olof Jeppsson, Uwe Kobold, John Barr, Andreas Finke, Wieland Hoelzel, Tadao Hoshino, Kor Miedema, Andrea Mosca, Pierluigi Mauri, Rita Paroni, Linda Thienpont, Masao Umemoto, and Cas Weykamp
Clinical Chemistry and Laboratory Medicine, 2002, Volume 40, Number 1
[42]
W. G. John
Diabetic Medicine, 2010, Volume 27, Number 7, Page 733
[43]
Cas Weykamp
Accreditation and Quality Assurance, 2010, Volume 15, Number 1, Page 3
[44]
Chan Hee Lee, Woo Jin Chang, Hyun Hee Chung, Hyun Jung Kim, Sang Hyun Park, Jun Sung Moon, Ji Eun Lee, Ji Sung Yoon, Kyung Ah Chun, Kyu Chang Won, Ihn Ho Cho, and Hyoung Woo Lee
Korean Diabetes Journal, 2009, Volume 33, Number 4, Page 306
[45]
A. Collier, S. Ghosh, D. F. Davidson, and E. S. Kilpatrick
Diabetic Medicine, 2009, Volume 26, Number 6, Page 573
[46]
Andrea Konnert, Sabine Arends, Stefan Schubert, Christoph Berding, Cas Weykamp, and Carla Siebelder
Accreditation and Quality Assurance, 2006, Volume 11, Number 7, Page 319
[48]
K. Makris, L. Spanou, A. Rambaouni-Antoneli, K. Koniari, I. Drakopoulos, D. Rizos, and A. Haliassos
Diabetic Medicine, 2008, Volume 25, Number 2, Page 174
[49]
F. Gorus, C. Mathieu, and E. Gerlo
Diabetologia, 2006, Volume 49, Number 1, Page 7
[50]
Akira Shimizu, Toyofumi Nakanishi, and Ayako Miyazaki
Mass Spectrometry Reviews, 2006, Volume 25, Number 5, Page 686
[51]
I. M. Penttilä, T. Halonen, K. Punnonen, and U. Tiikkainen
Scandinavian Journal of Clinical and Laboratory Investigation, 2005, Volume 65, Number 6, Page 453
[52]
Philip Home, Antonio Chacra, Juliana Chan, Alistair Emslie-Smith, Lea Sorensen, and Paul Van Crombrugge
Diabetes/Metabolism Research and Reviews, 2002, Volume 18, Number 4, Page 273
[53]
Diabetic Medicine, 2000, Volume 17, Number 1, Page 2

Comments (0)

Please log in or register to comment.
Log in